Significant Implications OfR-126 Expression With Respect to Its Target Gene in the Pathogenesis of Recurrent Pregnancy Losses (RPL)-a Study in High Incidence Zone

Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368(9535):601–11.

Article  PubMed  Google Scholar 

Pillarisetty LS, Mahdy H. Recurrent pregnancy loss. [Updated 2023 Aug 28]. In: StatPearls. Treasure Island, FL: StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK5544600

Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63.

Article  Google Scholar 

Christiansen, O. B. Epidemiology of recurrent pregnancy loss. In H. Carp, editor. Recurrent pregnancy loss: Causes, controversies and treatment (1st ed). Informa Healthcare. 2007; pp. 1-14.

Kim VN. Microrna biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6(5):376–85.

Article  CAS  PubMed  Google Scholar 

Kotlabova K, Doucha J, Hromadnikova I. Placental-specific microrna in maternal circulation-identification of appropriate pregnancy associated microRNAs with diagnostic potential. J Reprod Immunol. 2011;89(2):185–91.

Article  CAS  PubMed  Google Scholar 

Dai Y, Diao Z, Sun H, Li R, Qiu Z, Hu Y. Microrna-155 is involved in the remodelling of human-trophoblast-derived HTR8/SVneo cells induced by lipopolysaccharides. Hum Reprod. 2011;26(7):1882–91.

Article  CAS  PubMed  Google Scholar 

Liu B, Peng XC, Zheng XL, Wang J, Qin YW. Mir-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer. 2009;66(2):169–75.

Article  PubMed  Google Scholar 

El-Shorafa HM, Sharif FA. Dysregulation of micro-RNA contributes to the risk of unexplained recurrent pregnancy loss. Int J Reprod Contracept Obstet Gynecol. 2013;2(3):330–5.

Article  Google Scholar 

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the2 –(ΔΔCt). Methods. 2001;25:402–8.

Article  CAS  PubMed  Google Scholar 

Lien S, Lowman HB. Therapeutic anti-VEGF antibodies. Handb Exp Pharmacol. 2008;181(181):131–50.

Article  CAS  Google Scholar 

Miura K, Miura S, Yamasaki K, Higashijima A, Kinoshita A, Yoshiura K, et al. Identification of pregnancy-associated micrornas in maternal plasma. Clin Chem. 2010;56(11):1767–71.

Article  CAS  PubMed  Google Scholar 

Hong F, Li Y, Xu Y. Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-eclampsia. J Int Med Res. 2014;42(6):1243–51.

Article  PubMed  Google Scholar 

Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer. 2011;117(14):3193–200.

Article  CAS  PubMed  Google Scholar 

Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. Microrna-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One. 2011;6(1):e16617.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watahiki A, Wang Y, Morris J, Dennis K, O’Dwyer HM, Gleave M, et al. Micrornas associated with metastatic prostate cancer. PLoS ONE. 2011;6(9):e24950.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meister J, Schmidt MHH. miR-126 and miR-126*: new players in cancer. The Scientific World Journal. 2010;10:2090–100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agrawal S, Chaqour B. Microrna signature and function in retinal neovascularization. World J Biol Chem. 2014;5(1):1–11.

Article  PubMed  PubMed Central  Google Scholar 

Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, et al. MiR-126 regulates angiogenicsignaling and vascular integrity. Dev Cell. 2008;15(2):272–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific microrna miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261–71.

Article  PubMed  PubMed Central  Google Scholar 

Vuorela P, Carpén O, Tulppala M, Halmesmäki E. VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod. 2000;6(3):276–82.

Article  CAS  PubMed  Google Scholar 

Plaisier M, Dennert I, Rost E, Koolwijk P, van Hinsbergh VW, Helmerhorst FM. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions. Hum Reprod. 2009;24(1):185–97.

Article  CAS  PubMed  Google Scholar 

Pang L, Wei Z, Li O, Huang R, Qin J, Chen H, et al. An increase in vascular endothelial growth factor (VEGF) and VEGF soluble receptor-1 (sFlt-1) are associated with early recurrent spontaneous abortion. PLoS One. 2013;8(9):e75759.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He X, Chen Q. Reduced expressions of connexin 43 and VEGF in the first-trimester tissues from women with recurrent pregnancy loss. Reproductive Biology and Endocrinology: RB&E. 2016;14(1):46.

Article  Google Scholar 

Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, et al. Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod. 1993;48(5):1120–8.

Article  CAS  PubMed  Google Scholar 

Wheeler T, Evans PW, Anthony FW, Godfrey KM, Howe DT, Osmond C. Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth. Hum Reprod. 1999;14(6):1619–23.

Article  CAS  PubMed  Google Scholar 

De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med. 2012;44(1):1–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581–611.

Article  CAS  PubMed  Google Scholar 

Hiratsuka S, Kataoka Y, Nakao K, Nakamura K, Morikawa S, Tanaka S, et al. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Mol Cell Biol. 2005;25(1):355–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Khateeb GM, Mustafa FE, Sater MS, Almawi WY. Effect of the functional VEGFA-583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage. Fertil Steril. 2011;95(8):2471–3.

Article  CAS  PubMed  Google Scholar 

Pang LH, Li MJ, Li MQ, Yang DM, Shi L. Vascular endothelial growth factor (VEGF) and the VEGF soluble receptor-1 (sFlt-1) in chorionic villus tissue from Chinese women with early recurrent spontaneous abortion. J Int Med Res. 2011;39(3):830–7.

Article  CAS  PubMed  Google Scholar 

Zwierzchowska A, Iwan A, Hyc A, Suchońska B, Malejczyk J, Barcz E. Recurrent miscarriage is associated with increased ghrelin mRNA expression in the endometrium- a case-control study. Reprod Biol. 2018;18(1):12–7.

Article  PubMed  Google Scholar 

Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 2000;127(18):3941–6.

Article 

Comments (0)

No login
gif